Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:2175-2182

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okada, H.
Right arrow Articles by Fujii, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okada, H.
Right arrow Articles by Fujii, S.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Circulation. 1998;97:2175-2182.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Induction of Plasminogen Activator Inhibitor Type 1 and Type 1 Collagen Expression in Rat Cardiac Microvascular Endothelial Cells by Interleukin-1 and Its Dependence on Oxygen-Centered Free Radicals

Hitoshi Okada, MD; Janet Woodcock-Mitchell, PhD; John Mitchell, PhD; Tomohiro Sakamoto, MD; Kousuke Marutsuka, MD; Burton E. Sobel, MD; ; Satoshi Fujii, MD, PhD

From the Departments of Medicine (H.O., T.S., K.M., B.E.S., S.F.) and Molecular Physiology and Biophysics (J.W.-M., J.M.), The University of Vermont, College of Medicine (Burlington).

Correspondence to Satoshi Fujii, MD, PhD, The University of Vermont, College of Medicine, B-227 Given Building, Burlington, VT 05405. E-mail sfujii{at}zoo.uvm.edu

Background—Ischemia with or without reperfusion induces the release of diverse products from monocytes, including cytokines such as interleukin-1 (IL-1). To determine whether these phenomena modulate fibrinolysis and potentially exacerbate impairment of the macrocirculation, microcirculation, or both, we characterized the effects of IL-1 on the expression of fibrinolytic system and matrix proteins in rat cardiac microvascular endothelial cells (CMECs).

Methods and Results—Confluent CMECs were exposed to IL-1 in serum-free medium for 24 hours, and cell-conditioned medium was assayed for plasminogen activator inhibitor type 1 (PAI-1), the primary physiological inhibitor of plasminogen activators, and for type 1 collagen with Western blotting. IL-1 (2 ng/mL) specifically increased the accumulation of PAI-1 (4.4±0.6-fold; mean±SD; n=9) without affecting tissue plasminogen activator (t-PA) or urokinase plasminogen activator (u-PA) levels, which remained unchanged. IL-1 increased the accumulation of collagen in conditioned media by 3.5±0.7-fold (n=6). Conversely, the accumulation of both PAI-1 and collagen induced by IL-1 was inhibited with an IL-1 receptor antagonist (200 ng/mL; n=6) and with cycloheximide (10 µg/mL; n=6), implying that protein synthesis was a requirement for the effect. To determine whether the IL-1 effect was mediated by induction of oxygen-centered free radical production, known to be induced by IL-1, we exposed the cells to the hydroxyl radical scavenger tetramethylthiourea (10 mmol/L) and observed abolition of the IL-1–induced increase in the expression of PAI-1 and collagen (n=6). Conversely, superoxides (generated with 10 mU/mL xanthine oxidase plus 0.6 mmol/L hypoxanthine, and 100 µmol/L hydrogen peroxide) induced the accumulation of PAI-1 and collagen (n=6). IL-1 (1 µg/kg body wt) and lipopolysaccharide (50 µg/kg body wt) administered in vivo increased PAI-1 protein in rat hearts as detected with Western blotting and PAI-1 immunostaining of rat heart microvessels, indicating the effects delineated in vitro were paralleled by effects in vivo.

Conclusions—These results indicate that IL-1–induced oxygen-centered free radicals stimulate elaboration of PAI-1 and collagen by CMECs. Accordingly, microvascularly mediated inhibition of fibrinolysis may predispose to the persistence of microvascular thrombi, thereby contributing to impaired microcirculatory function, the no-reflow phenomenon, and cardiac dysfunction after ischemia and reperfusion.


Key Words: endothelium • coronary disease • interleukins • plasminogen activators




This article has been cited by other articles:


Home page
CirculationHome page
I. Ikonomidis, J. P. Lekakis, M. Nikolaou, I. Paraskevaidis, I. Andreadou, T. Kaplanoglou, P. Katsimbri, G. Skarantavos, P. N. Soucacos, and D. T. Kremastinos
Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
Circulation, May 20, 2008; 117(20): 2662 - 2669.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C. M. Matter, Z. Yang, T. F. Luscher, et al.
Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents
Circulation, October 3, 2006; 114(14): 1512 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. R. Madamanchi and M. S. Runge
Five Easy Pieces: The Obesity Paradigm
Circ. Res., March 17, 2006; 98(5): 576 - 578.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Cai
Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences
Cardiovasc Res, October 1, 2005; 68(1): 26 - 36.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. G. McLaughlin, G. W. Stone, E. Aymong, G. Gardner, R. Mehran, A. J. Lansky, C. L. Grines, J. E. Tcheng, D. A. Cox, T. Stuckey, et al.
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial
J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. E. Sobel, D. J. Taatjes, and D. J. Schneider
Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1979 - 1989.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z.-Z. Yang, A. Y. Zhang, F.-X. Yi, P.-L. Li, and A.-P. Zou
Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells
Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1207 - F1215.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. A. Gunnett, D. D. Heistad, and F. M. Faraci
Interleukin-10 Protects Nitric Oxide-Dependent Relaxation During Diabetes: Role of Superoxide
Diabetes, June 1, 2002; 51(6): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Zhao, D. R. Spitz, L. W. Oberley, and M. E. C. Robbins
Redox Modulation of the Pro-Fibrogenic Mediator Plasminogen Activator Inhibitor-1 following Ionizing Radiation
Cancer Res., July 1, 2001; 61(14): 5537 - 5543.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. K. M. T. Zaman, S. Fujii, H. Sawa, D. Goto, N. Ishimori, K. Watano, T. Kaneko, T. Furumoto, T. Sugawara, I. Sakuma, et al.
Angiotensin-Converting Enzyme Inhibition Attenuates Hypofibrinolysis and Reduces Cardiac Perivascular Fibrosis in Genetically Obese Diabetic Mice
Circulation, June 26, 2001; 103(25): 3123 - 3128.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Takeda, T. Ichiki, T. Tokunou, N. Iino, S. Fujii, A. Kitabatake, H. Shimokawa, and A. Takeshita
Critical Role of Rho-Kinase and MEK/ERK Pathways for Angiotensin II-Induced Plasminogen Activator Inhibitor Type-1 Gene Expression
Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 868 - 873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. J. Thannickal and B. L. Fanburg
Reactive oxygen species in cell signaling
Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Gunnett, D. D. Heistad, D. J. Berg, and F. M. Faraci
IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1555 - H1562.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Birgel, H. Gottschling-Zeller, K. Rohrig, and H. Hauner
Role of Cytokines in the Regulation of Plasminogen Activator Inhibitor-1 Expression and Secretion in Newly Differentiated Subcutaneous Human Adipocytes
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1682 - 1687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Bertuglia and A. Colantuoni
Protective effects of leukopenia and tissue plasminogen activator in microvascular ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H755 - H761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Kashiwagi, K. Shinozaki, Y. Nishio, H. Maegawa, Y. Maeno, A. Kanazawa, H. Kojima, M. Haneda, H. Hidaka, H. Yasuda, et al.
Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E976 - E983.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, Herbert De Raedt, and C. J. Vrints
Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction : Importance of Microvascular Reperfusion Injury on Clinical Outcome
Circulation, April 20, 1999; 99(15): 1972 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Gorlach, I. Diebold, V. B. Schini-Kerth, U. Berchner-Pfannschmidt, U. Roth, R. P. Brandes, T. Kietzmann, and R. Busse
Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells : Role of the p22phox-Containing NADPH Oxidase
Circ. Res., July 6, 2001; 89(1): 47 - 54.
[Abstract] [Full Text] [PDF]